Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Long-term survival among men with conservatively treated localized prostate cancer.

Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J.

JAMA. 1995 Aug 23-30;274(8):626-31.

PMID:
7637143
3.

[Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].

SouliƩ M, Villers A, Richaud P, Prapotnich D, Ruffion A, Grosclaude P.

Prog Urol. 2001 Dec;11(6):1195-204. Review. French.

PMID:
11859652
4.

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience.

Han M, Partin AW, Pound CR, Epstein JI, Walsh PC.

Urol Clin North Am. 2001 Aug;28(3):555-65. Review.

PMID:
11590814
5.

An analysis of watchful waiting for clinically localized prostate cancer.

Steinberg GD, Bales GT, Brendler CB.

J Urol. 1998 May;159(5):1431-6. Review.

PMID:
9554328
6.

Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.

Sammon JD, Abdollah F, D'Amico A, Gettman M, Haese A, Suardi N, Vickers A, Trinh QD.

Eur Urol. 2015 Nov;68(5):756-65. doi: 10.1016/j.eururo.2015.03.020. Epub 2015 Mar 26. Review.

7.

A systematic literature review of life expectancy prediction tools for patients with localized prostate cancer.

Kent M, Vickers AJ.

J Urol. 2015 Jun;193(6):1938-42. doi: 10.1016/j.juro.2014.11.082. Epub 2014 Nov 15. Review.

8.

Will focal therapy become a standard of care for men with localized prostate cancer?

Ahmed HU, Pendse D, Illing R, Allen C, van der Meulen JH, Emberton M.

Nat Clin Pract Oncol. 2007 Nov;4(11):632-42. Review.

PMID:
17965641
9.

Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer [Internet].

Wilt TJ, Shamliyan T, Taylor B, MacDonald R, Tacklind J, Rutks I, Koeneman K, Cho CS, Kane RL.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Feb.

Supplemental Content

Support Center